{"nct_id":"NCT03560739","title":"A 12 Week Randomized Open Label Parallel Group Multicenter Study to Evaluate Bioequivalence of 20 mg Subcutaneous Ofatumumab Injected by Pre-filled Syringe or Autoinjector in Adult RMS Patients","status":"COMPLETED","status_verified_date":"2021-10","start_date":"2018-09-11","start_date_type":"ACTUAL","primary_completion_date":"2019-08-26","primary_completion_date_type":"ACTUAL","completion_date":"2020-05-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}